Kathleen A. Marshall
Ms. Marshall holds a BA from Amherst College and an MS in Regulatory Affairs from Northeastern University. Kathleen began her medical device career at Advanced Cardiovascular Systems (ACS—later Guidant/Abbott) and, subsequently, the Senior Management team of Cardiovascular Imaging Systems (CVIS—later acquired by Boston Scientific). She was a founding member of Cardiothoracic Systems, Inc. (CTSI) and led the clinical development of the company resulting in an initial public offering of $86 million in 1996. Subsequently she joined Embol-X (later acquired by Edwards Lifesciences) as Vice President of Marketing during which she managed European clinical studies. In 2003 Ms. Marshall created MAXIS Medical, a clinical market development company, providing services in strategic clinical research, regulatory affairs and market development to emerging medical device companies.